WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-07-01·Latest →

Linde plc Stock Analysis

OW

LIN Equity Research — OVERWEIGHT — July 2026

Rating date

Jul 1, 2026

40 days ago

Desk view

OW

5D move

—

Awaiting market data

Peer rank

71p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · LIN

Over the full 12-month window (July 2025 – June 2026), LIN's price trajectory was steadily upward. The stock opened near $464 in early July 2025, traded in a relatively tight $450–$470 range through H2 2025, and then began a more decisiv...

Desk rating

OW

Tactical OW · 12M OW

Horizon

Long-term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

OVERWEIGHT

Catalysts

  • LIN is in a well-defined long-term uptrend, with both the 50-day and 200-day SMAs sloping upward and in a golden-cross configuration.
  • Short-term momentum is bullish but not extreme — RSI at 63 leaves headroom before overbought levels, and MACD continues to strengthen.
  • The stock broke above the $500 psychological level in early June and has held above it, which is a positive technical development.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

LIN Research Note

Full desk note for Jul 1, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

23 min read

WebserviceX · Agentic Research Desk

LIN Equity Research Note

Published Jul 1, 2026 · Desk view OVERWEIGHT · Generated 2026-07-02T20:33:17Z · Maintained by Walter Vijayakumar · Methodology · Track record

LIN Stock Rating Summary

LIN bias

OVERWEIGHT

Horizon

Long-term

LIN key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

LIN catalyst watch

LIN is in a well-defined long-term uptrend, with both the 50-day and 200-day SMAs sloping upward and in a golden-cross configuration.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

—Awaiting market dataPeer 71p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-07-02T20:45:23.208174+00:00.

5D move

—

2026-07-01 → awaiting

Outcome

Awaiting market data

5D trend

+3.46%

Vol (20D ann.)

+21.03%

vs SPY: +1.75%

Close 533.55 → — (USD, vendor closes)

Batch scorecard · 2026-07-01 · LIN

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace 7b9f3d1d…

No QC issues recorded.